17 Aug 2016 07:00
Consort Medical plc
17 August 2016
Directorate Change
Consort Medical plc (LSE: CSRT) ("Consort", "Consort Medical" or the "Group"), a leading, global, single source pharma services drug and delivery device company, today announces that Richard Cotton, Group Chief Financial Officer, will be leaving the business in order to accept the position of Chief Financial Officer at Dechra Pharmaceuticals PLC, a FTSE 250 Company. Richard will leave Consort after the interim results in December 2016, to ensure an orderly transition. The search for his successor is underway, and a further announcement will be made in due course.
Dr Peter Fellner, Chairman of Consort Medical, commented:
"Richard has made many significant contributions during his four years at Consort. Not least of these has been his central role in the acquisition and integration of Aesica, allowing Consort to begin to realise its vision of becoming a leading single source pharma services drug and delivery device company. Richard leaves the Company in robust financial shape and well positioned to support the growth aspirations of our multi-faceted business. The Board and I would like to thank Richard for his contribution, commitment and hard work during a time of significant change at the Group and we wish him well as he embarks on the next stage of his career."
Enquiries:
Consort Medical | Tel: +44 (0) 1442 867920 |
Jonathan Glenn - Chief Executive Officer | |
Richard Cotton - Chief Financial Officer | |
FTI Consulting | Tel: +44 (0) 20 3727 1000 |
Ben Atwell / Simon Conway |
Consort Medical plc is a leading, global, single source pharma services drug and delivery device company. We are at the leading edge of innovation and we are committed to investing in patient, clinician and customer driven innovation to create new treatments, new markets and new opportunities.
Our businesses
Bespak is a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, injectables ocular products, and the manufacture of devices for the point of care diagnostics market. www.bespak.com.
Aesica is a leading provider of finished dose and active pharmaceutical ingredient (API) development and manufacturing services to pharmaceutical partners. www.aesica-pharma.com.
We employ more than 2000 people globally of which 1400 are located in the UK. We have UK facilities in King's Lynn, Cambridge, Nelson, Milton Keynes, Cramlington, Queenborough and Hemel Hempstead, German facilities in Monheim and Zwickau and a facility in Pianezza, Italy. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT). www.consortmedical.com.